Status:
RECRUITING
Use of a Generative AI (Gen-AI) Chatbot for Anxiety and Depression Among Persons With Cannabis Use
Lead Sponsor:
Trustees of Dartmouth College
Collaborating Sponsors:
National Institute on Drug Abuse (NIDA)
Conditions:
Cannabis Use Disorder
Anxiety
Eligibility:
All Genders
18+ years
Phase:
PHASE1
Brief Summary
The goal of this clinical trial is to learn if Therabot-CALM (Cannabis, Anxiety, Low Mood) has acceptability among users and could work to improve the symptoms of persons with cannabis use disorder an...
Detailed Description
Participants will complete a two-stage screening process via REDCap to determine their eligibility for enrollment. Participants who meet criteria and provide informed consent will be enrolled and part...
Eligibility Criteria
Inclusion
- Is 18 years or older.
- Meet criteria for current CUD (CUDIT-R\>=12) and MDD (PHQ-9\>=10), and/or GAD (GAD-7\>=10).
- Have reliable access to the internet and a compatible device for Therabot-CALM.
- Have willingness and capacity to provide informed consent and commit to participating in all assessments and interventions during the study.
- Attend the first interview.
Exclusion
- Moderate to High risk of STBs as determined by the C-SSRS or baseline questionnaires.
- Current psychosis (as determined by brief psychosis screen).
- Current participation in another digital mental health intervention.
Key Trial Info
Start Date :
April 13 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT06920238
Start Date
April 13 2025
End Date
December 1 2025
Last Update
September 8 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
46 Centerra Parkway, Suite 300, Office #333S
Lebanon, New Hampshire, United States, 03766